Authors:
Reske, SN
Bunjes, D
Buchmann, I
Seitz, U
Glatting, G
Neumaier, B
Kotzerke, J
Buck, A
Martin, H
Dohner, H
Bergmann, L
Citation: Sn. Reske et al., Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation, EUR J NUCL, 28(7), 2001, pp. 807-815
Authors:
Kotzerke, J
Glatting, G
van den Hoff, J
Hoher, M
Neumaier, B
Wohrle, J
Reske, SN
Citation: J. Kotzerke et al., Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans, EUR J NUCL, 28(3), 2001, pp. 340-345
Authors:
Schirrmeister, H
Kuhn, T
Guhlmann, A
Santjohanser, C
Horster, T
Nussle, K
Koretz, K
Glatting, G
Rieber, A
Kreienberg, R
Buck, TC
Reske, SN
Citation: H. Schirrmeister et al., Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures, EUR J NUCL, 28(3), 2001, pp. 351-358
Authors:
Seitz, U
Wagner, M
Vogg, AT
Glatting, G
Neumaier, B
Greten, FR
Schmid, RM
Reske, SN
Citation: U. Seitz et al., In vivo evaluation of 5-[F-18]fluoro-2 '-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model, CANCER RES, 61(10), 2001, pp. 3853-3857
Authors:
Buchmann, I
Reinhardt, M
Elsner, K
Bunjes, D
Altehoefer, C
Finke, J
Moser, E
Glatting, G
Kotzerke, J
Guhlmann, CA
Schirrmeister, H
Reske, SN
Citation: I. Buchmann et al., 2-(Fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma - A bicenter trial, CANCER, 91(5), 2001, pp. 889-899
Authors:
Bunjes, D
Buchmann, I
Duncker, C
Seitz, U
Kotzerke, J
Wiesneth, M
Dohr, D
Stefanic, M
Buck, A
Harsdorf, SV
Glatting, G
Grimminger, W
Karakas, T
Munzert, G
Dohner, H
Bergmann, L
Reske, SN
Citation: D. Bunjes et al., Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study, BLOOD, 98(3), 2001, pp. 565-572
Authors:
Gerhard, A
Neumaier, B
Elitok, E
Glatting, G
Ries, V
Tomczak, R
Ludolph, AC
Reske, SN
Citation: A. Gerhard et al., In vivo imaging of activated microglia using [C-11]PK11195 and positron emission tomography in patients after ischemic stroke, NEUROREPORT, 11(13), 2000, pp. 2957-2960
Authors:
Diederichs, CG
Staib, L
Vogel, J
Glasbrenner, B
Glatting, G
Brambs, HJ
Beger, HG
Reske, SN
Citation: Cg. Diederichs et al., Values and limitations of F-18-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses, PANCREAS, 20(2), 2000, pp. 109-116
Authors:
Kotzerke, J
Glatting, G
Seitz, U
Rentschler, M
Neumaier, B
Bunjes, D
Duncker, C
Dohr, D
Bergmann, L
Reske, SN
Citation: J. Kotzerke et al., Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: Differences in dosimetry and biokinetics of Re-188- and Tc-99m-labeled anti-NCA-95 MAbs, J NUCL MED, 41(3), 2000, pp. 531-537
Citation: G. Glatting et al., Simultaneous iterative reconstruction for emission and attenuation images in positron emission tomography, MED PHYS, 27(9), 2000, pp. 2065-2071
Authors:
Schirrmeister, H
Guhlmann, A
Kotzerke, J
Santjohanser, C
Kuhn, T
Kreienberg, R
Messer, P
Nussle, K
Elsner, K
Glatting, G
Trager, H
Neumaier, B
Diederichs, C
Reske, SN
Citation: H. Schirrmeister et al., Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography, J CL ONCOL, 17(8), 1999, pp. 2381-2389
Authors:
Seitz, U
Neumaier, B
Glatting, G
Kotzerke, J
Bunjes, D
Reske, SN
Citation: U. Seitz et al., Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia, EUR J NUCL, 26(10), 1999, pp. 1265-1273
Authors:
Schirrmeister, H
Guhlmann, A
Elsner, K
Kotzerke, J
Glatting, G
Rentschler, M
Neumaier, B
Trager, H
Nussle, K
Reske, SN
Citation: H. Schirrmeister et al., Sensitivity in detecting osseous lesions depends on anatomic localization:Planar bone scintigraphy versus F-18 PET, J NUCL MED, 40(10), 1999, pp. 1623-1629
Citation: G. Glatting et al., Iterative reconstruction for attenuation correction in positron emission tomography: Maximum likelihood for transmission and blank scan, MED PHYS, 26(9), 1999, pp. 1838-1842
Citation: G. Glatting et Sn. Reske, Treatment of radioactive decay in pharmacokinetic modeling: Influence on parameter estimation in cardiac N-13-PET, MED PHYS, 26(4), 1999, pp. 616-621
Authors:
Guhlmann, A
Brecht-Krauss, D
Suger, G
Glatting, G
Kotzerke, J
Kinzl, L
Reske, SN
Citation: A. Guhlmann et al., Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis, J NUCL MED, 39(12), 1998, pp. 2145-2152